Home
>
National Drug Code (NDC)
>
Stavudine
Stavudine - 31722-517-01 - (Stavudine)
Drug Information of Stavudine
| Product NDC: | 31722-517 |
| Proprietary Name: | Stavudine |
| Non Proprietary Name: | Stavudine |
| Active Ingredient(s): | 30 mg/1 & nbsp; Stavudine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Stavudine
| Product NDC: | 31722-517 |
| Labeler Name: | Camber Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078957 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20081229 |
Package Information of Stavudine
| Package NDC: | 31722-517-01 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (31722-517-01) |
NDC Information of Stavudine
| NDC Code | 31722-517-01 |
| Proprietary Name | Stavudine |
| Package Description | 100 CAPSULE in 1 BOTTLE (31722-517-01) |
| Product NDC | 31722-517 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Stavudine |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20081229 |
| Marketing Category Name | ANDA |
| Labeler Name | Camber Pharmaceuticals, Inc. |
| Substance Name | STAVUDINE |
| Strength Number | 30 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
